A decade of incremental advances in radiopharmaceuticals: a promising future ahead
Yu Xiong, Hui Jian, Xiaowen Han, Lizhi Li, Liangxue Zhou · 2024
Read A decade of incremental advances in radiopharmaceuticals: a promising future ahead by Yu Xiong, Hui Jian, Xiaowen Han, Lizhi Li, Liangxue Zhou (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11616306.txt.
Description
Yu Xiong and co-authors survey a decade of growth in radiopharmaceuticals, drugs labeled with radioisotopes for imaging or therapy. Their 2024 letter focuses on radionuclide drug conjugates, precision drugs that carry a radioactive payload to a target. Two approved products showed the approach can work well in patients.
The authors counted trials of such conjugates over ten years using an industry database. A few hundred trials were found, yet barely half remain active, and most finished trials sit in early phases. The letter frames this as steady, incremental progress rather than a breakthrough wave. It argues the field's promise is real but young, with many candidates still proving safety and benefit. The survey gives clinicians and investors a grounded map of where the area stands.
Catalog record
| CREATOR | Yu Xiong, Hui Jian, Xiaowen Han, Lizhi Li, Liangxue Zhou |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |